Compliance Rate

Compliance Rate 100.0%
Compliant submissions 1
Incompliant submissions 0
Total trials 1

My Organizations' Clinical Trials

Showing 1600 of 1674 entries
View as:

Evaluating Implementation and Scale-Up of Nigeria's National Sodium Reduction Program

Phase: N/A Priority: Normal
NCT ID: NCT04765865 Org: User:
Start: 06/26/23 End: 05/01/27 Due: 05/01/28

Intubated ICU Patients

Phase: N/A Priority: Normal
NCT ID: NCT02171091 Org: User:
Start: 12/01/16 End: 08/08/17 Due: 08/08/18

Pembrolizumab With Locally Delivered Radiation Therapy for the Treatment of Metastatic Esophageal Cancers

Phase: N/A Priority: Normal
NCT ID: NCT02642809 Org: User:
Start: 06/08/16 End: 08/03/21 Due: 08/03/22

Belatacept Pilot Study in Lung Transplantation Immunosuppression in Lung Transplantation

Phase: N/A Priority: Normal
NCT ID: NCT03388008 Org: User:
Start: 12/17/19 End: 08/31/22 Due: 08/31/23

ADI-PEG20, Obesity and Prediabetes

Phase: N/A Priority: Normal
NCT ID: NCT05829239 Org: User:
Start: 04/01/24 End: 05/01/24 Due: 05/01/25

Impact of Basic Needs Assessment and Support to Improve Colposcopy Show Rate

Phase: N/A Priority: Normal
NCT ID: NCT05458960 Org: User:
Start: 03/28/25 End: 12/31/26 Due: 12/31/27

Tazemetostat and Pembrolizumab in Patients With Pembrolizumab- or Nivolumab-Resistant, Recurrent or Metastatic Head and Neck Squamous-Cell Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT04624113 Org: User:
Start: 04/14/21 End: 02/17/24 Due: 02/17/25

Ivosidenib for Patients With Clonal Cytopenia of Undetermined Significance and Mutations in IDH1

Phase: N/A Priority: Normal
NCT ID: NCT05030441 Org: User:
Start: 04/01/22 End: 01/31/30 Due: 01/31/31

Targeting Pediatric Brain Tumors and Relapsed/Refractory Solid Tumors With Sodium Glucose Cotransporter 2 Inhibitors (SGLT2i)

Phase: N/A Priority: Normal
NCT ID: NCT05521984 Org: User:
Start: 04/03/23 End: 11/30/26 Due: 11/30/27

Goserelin and Letrozole or Anastrozole in Premenopausal Patients With Stage II-III Estrogen Receptor-Positive Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01368263 Org: User:
Start: 09/30/11 End: 05/31/13 Due: 05/31/14

Combination Liposomal Irinotecan and Pembrolizumab For Triple-Negative Breast Cancer (TNBC) With Brain Metastases (BM)

Phase: N/A Priority: Normal
NCT ID: NCT05255666 Org: User:
Start: 07/31/23 End: 01/31/30 Due: 01/31/31

Feasibility and Optimization of a Cognitive Intervention for Parkinson Disease

Phase: N/A Priority: Normal
NCT ID: NCT02826785 Org: User:
Start: 05/31/14 End: 07/31/16 Due: 07/31/17

Evaluating the Roles of Estrogen and Progesterone in Heart Metabolism

Phase: N/A Priority: Normal
NCT ID: NCT00565916 Org: User:
Start: 08/31/04 End: 01/31/08 Due: 01/31/09

Treatment Efforts Addressing Child Weight Management by Unifying Patients, Parents & Providers

Phase: N/A Priority: Normal
NCT ID: NCT03843424 Org: User:
Start: 09/12/19 End: 07/26/24 Due: 07/26/25

Pilot Study for Postoperative Machine Learning

Phase: N/A Priority: Normal
NCT ID: NCT04877535 Org: User:
Start: 06/03/21 End: 05/11/23 Due: 05/11/24

Examining Racial and Socioeconomic Differences in Chronic Low Back Pain

Phase: N/A Priority: Normal
NCT ID: NCT05991440 Org: User:
Start: 04/22/24 End: 06/30/27 Due: 06/30/28

Weight Loss and Exercise in Obese, Physically Limited, Older Women and Men

Phase: N/A Priority: Normal
NCT ID: NCT00146107 Org: User:
Start: 01/31/05 End: 12/31/10 Due: 12/31/11

Improving Maternal Cardiovascular Outcomes Through the Implementation of a Hypertensive Disorders of Pregnancy Bundle in Nigeria

Phase: N/A Priority: Normal
NCT ID: NCT06859359 Org: User:
Start: 08/08/24 End: 06/30/29 Due: 06/30/30

Safety of Reduced Infliximab Infusion Time

Phase: N/A Priority: Normal
NCT ID: NCT05340764 Org: User:
Start: 08/01/20 End: 05/04/23 Due: 05/04/24

Conversion From MPA to Zortress (Everolimus) for GI Toxicity Post-renal Transplantation

Phase: N/A Priority: Normal
NCT ID: NCT02974686 Org: User:
Start: 11/30/16 End: 09/30/19 Due: 09/30/20

Atheroma Reduction With Chloroquine in Patients With the Metabolic Syndrome (ARCH-MS)

Phase: N/A Priority: Normal
NCT ID: NCT00455403 Org: User:
Start: 04/30/06 End: 12/31/09 Due: 12/31/10

Harnessing Mobile Technology to Reduce Mental Health Disorders in College Populations

Phase: N/A Priority: Normal
NCT ID: NCT04162847 Org: User:
Start: 10/07/19 End: 12/31/23 Due: 12/31/24

Embedded Palliative Care in the MICU

Phase: N/A Priority: Normal
NCT ID: NCT06574672 Org: User:
Start: 07/29/24 End: 06/30/26 Due: 06/30/27

Determining the Feasibility of Outpatient Parenteral Antibiotic Therapy for Persons Who Inject Opioids

Phase: N/A Priority: Normal
NCT ID: NCT05300581 Org: User:
Start: 03/16/22 End: 03/31/26 Due: 03/31/27

The Use of Sensory or Motor Cues Using Electrical Stimulation to Reduce Gait Freezing in Patients With Parkinson Disease

Phase: N/A Priority: Normal
NCT ID: NCT00762814 Org: User:
Start: 05/31/08 End: 06/30/09 Due: 06/30/10